About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2019 Multidisciplinary Thoracic Cancers Symposium
AACR Annual Meeting 2019
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
2019 Genitourinary Cancers Symposium
2019 Gastrointestinal Cancers Symposium
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Jun J. Mao, MD, MSCE, and Jyothirmai Gubili, MS,"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
SGO 2019: Brachytherapy Boost Added to EBRT and Chemotherapy in Advanced Cervical Cancer
SGO 2018: Treatment With Maintenance Niraparib in Recurrent Ovarian Cancer Extends Time Without Symptoms or Toxicity
SGO 2019: HPV Vaccine Uptake in the Deep South
FDA Approves Atezolizumab for Extensive-Stage Small Cell Lung Cancer
EAU 2019: Testosterone Replacement Therapy May Slow Recurrence in Low-Risk Prostate Cancer
Most Read Stories
FDA Pipeline: Assay Approval, Breakthrough Designations for AI Technology and CLL, and More
2019 Thoracic Cancers Symposium: Trends in Use of Prophylactic Cranial Irradiation for Extensive-Stage SCLC
HHS Secretary Appoints Norman E. Sharpless, MD, as FDA Acting Commissioner
Pembrolizumab/Axitinib Combination Improves Outcomes vs Sunitinib in Kidney Cancer
Nivolumab Plus Ipilimumab in Advanced NSCLC: Outcomes by PD-L1 and Tumor Mutational Burden Status
© 2019 HSP News Service, L.L.C.